Karius looks to $165M B round to spur growth of diagnostic business

Karius has raised $165 million in a series B to grow its customer base and advance its DNA-based blood test technology.

SoftBank Vision Fund 2 led Karius Inc.’s financing. Fellow new investors General Catalyst and HBM Healthcare Investments, and existing investors Khosla Ventures and LightSpeed Venture Partners also participated...